Evidence supporting the use of: Senna
For the health condition: Colon (atonic)
Synopsis
Source of validity: Scientific
Rating (out of 5): 4
Senna is primarily used as a stimulant laxative and has a longstanding place in both traditional and modern medicine for the treatment of constipation, including atonic (lazy or weakened) colon. The active compounds in senna, called sennosides, are well studied. They work by stimulating peristalsis (muscular contractions) in the colon, thereby promoting bowel movements. Several clinical studies and regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), recognize senna as effective for short-term relief of constipation, which can be a symptom of atonic colon. The condition of atonic colon involves reduced motility and muscle tone in the large intestine, leading to chronic constipation. By directly stimulating colonic motility, senna addresses the underlying pathophysiology of atonic colon.
However, while the evidence base for short-term use is strong, long-term use of senna is not recommended due to the risk of developing tolerance, dependence, and potential worsening of colonic atony. Historical use of senna dates back centuries, particularly in traditional Arabic and Ayurvedic medicine, but its current use is well supported by scientific studies and clinical guidelines. Therefore, senna's use in treating atonic colon is justified by both tradition and robust scientific validation, particularly for short-term and symptomatic management.
Other health conditions supported by senna
Colon (atonic)Constipation (adults)
Constipation (children)
Digestion (poor)
Irritable Bowel Syndrome